Losartan Potassium & HCTZ Tablets 50mg/12 — Class II drug recall D-0892-2022
Terminated recall by Preferred Pharmaceuticals, Inc., reported 2022-06-01, distributed in CA, FL. CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
| Recall number | D-0892-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Preferred Pharmaceuticals, Inc., Anaheim, CA, United States |
| Recall initiated | 2022-05-03 |
| Classified | 2022-05-24 |
| Reported by FDA | 2022-06-01 |
| Terminated | 2022-09-21 |
| Distributed | CA, FL |
| Reason classes | cgmp, specification failure |
| NDC | 68788-7758-03 |
| Lot numbers | H3021Q, K1721E |
| Expiration dates | 2023-02-28, 2023-04-30 |
Product
Losartan Potassium & HCTZ Tablets 50mg/12.5 mg, hydrochlorothiazide USP 12.5 mg, Pkg Size: 30, NDC: 68788-7758-03.
Reason for recall
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0892-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.